Phage Therapy: A Promising Solution in the Battle Against Superbugs.

  15 February 2024

Antimicrobial resistance (AMR), or the rise of “superbugs,” is a pressing global health concern. Bacteriophages, or phages, are viruses that target and infect bacteria, making them a potential long-term solution against evolving and resistant bacteria. Phage therapy has been used for over a century to treat bacterial infections, and recent cases have been used to combat drug-resistant infections like MRSA. Westmead Health Precinct is actively addressing challenges in matching appropriate phages and ensuring the safety and effectiveness of phage products. Phage Australia has co-founded the program, integrating it into clinical services. Since December 2021, patients in Australia have gained access to bacteriophage therapy through the Therapeutic Goods Administration Special Access Scheme, under the STAMP protocol. This progress highlights the potential of phage therapy as an alternative approach to combating AMR and treating difficult-to-treat infections.

Further reading: LinkedIn
Author(s): Ruby Lin
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed